160 related articles for article (PubMed ID: 11102674)
1. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres.
Barman SP; Lunsford L; Chambers P; Hedley ML
J Control Release; 2000 Dec; 69(3):337-44. PubMed ID: 11102674
[TBL] [Abstract][Full Text] [Related]
2. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
Cho SW; Song SH; Choi YW
Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
[TBL] [Abstract][Full Text] [Related]
3. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles.
Dunne M; Bibby DC; Jones JC; Cudmore S
J Control Release; 2003 Sep; 92(1-2):209-19. PubMed ID: 14499198
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres.
Rojas J; Pinto-Alphandary H; Leo E; Pecquet S; Couvreur P; Fattal E
Int J Pharm; 1999 Jun; 183(1):67-71. PubMed ID: 10361157
[TBL] [Abstract][Full Text] [Related]
7. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.
Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT
Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.
Walter E; Moelling K; Pavlovic J; Merkle HP
J Control Release; 1999 Sep; 61(3):361-74. PubMed ID: 10477808
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
Morlock M; Kissel T; Li YX; Koll H; Winter G
J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
[TBL] [Abstract][Full Text] [Related]
11. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release.
Gasper MM; Blanco D; Cruz ME; Alonso MJ
J Control Release; 1998 Mar; 52(1-2):53-62. PubMed ID: 9685935
[TBL] [Abstract][Full Text] [Related]
12. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
13. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
Frangione-Beebe M; Rose RT; Kaumaya PT; Schwendeman SP
J Microencapsul; 2001; 18(5):663-77. PubMed ID: 11508771
[TBL] [Abstract][Full Text] [Related]
14. Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
Hedley ML
Expert Opin Biol Ther; 2003 Sep; 3(6):903-10. PubMed ID: 12943449
[TBL] [Abstract][Full Text] [Related]
15. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
16. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
[TBL] [Abstract][Full Text] [Related]
17. Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres.
Meinel L; Illi OE; Zapf J; Malfanti M; Peter Merkle H; Gander B
J Control Release; 2001 Jan; 70(1-2):193-202. PubMed ID: 11166419
[TBL] [Abstract][Full Text] [Related]
18. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Lavelle EC; Yeh MK; Coombes AG; Davis SS
Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system.
Seemann S; Hauff P; Schultze-Mosgau M; Lehmann C; Reszka R
Pharm Res; 2002 Mar; 19(3):250-7. PubMed ID: 11934230
[TBL] [Abstract][Full Text] [Related]
20. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.
Takahata H; Lavelle EC; Coombes AG; Davis SS
J Control Release; 1998 Jan; 50(1-3):237-46. PubMed ID: 9685890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
